438
Participants
Start Date
October 9, 2020
Primary Completion Date
October 29, 2021
Study Completion Date
December 21, 2021
Asunercept
Asunercept (APG101) will be administered once per week as an i.v. infusion
Republican Clinical Infectious Hospital n.a. professor A.F. Agafonov, Kazan'
Scientific Research lnstitute fоr Соmрlех lssues of Cardiovascular Diseases, Kemerovo
"Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation", Krasnodar
"State Budgetary Healthcare Institution Scientific Research Institute - Regional clinical hospital No. 1 n.a. professor S.V. Ochapovsky of the Ministry of Healthcare of Krasnodar Krai", Krasnodar
"State Budgetary Institution of Health of the Nizhny Novgorod Region Infectious Clinical Hospital No. 2 of Nizhny Novgorod", Nizhny Novgorod
Ryazan State Medical University n.a. academician I.P. Pavlov, Ryazan
"Saint Petersburg state budgetary healthcare institution City hospital of Saint George the great Martyr", Saint Petersburg
Hospital Universitario Infanta Leonor, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Universitario Infanta Sofia, San Sebastián de los Reyes
Hospital Clínico Universitario Lozano Blesa, Zaragoza
Lead Sponsor
Apogenix AG
INDUSTRY